Hydroxychloroquine/ chloroquine as a treatment choice or prophylaxis for Covid-19 at the primary care level in developing countries: A Primum non Nocere dilemma-Reference-Cited by-同舟云学术

Hydroxychloroquine/ chloroquine as a treatment choice or prophylaxis for Covid-19 at the primary care level in developing countries: A Primum non Nocere dilemma

Published:2020-08 Issue: Volume:415 Page:116972
ISSN:0022-510X
Container-title:Journal of the Neurological Sciences
language:en
Short-container-title:Journal of the Neurological Sciences

Author:

Medina Marco T.,Moncada Sir Salvador

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology

Reference5 articles.

1. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial;Gautret;Int. J. Antimicrob. Agents,2020

2. Observational study of hydroxychloroquine in hospitalized patients with covid-19;Geleris;Engl. J. Med.,2020

3. Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York State;Rosenberg;JAMA,2020

4. Remdesivir for the treatment of covid-19 - preliminary report;Beigel;N. Engl. J. Med.,2020

5. Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: a scientific statement from the Indian Heart Rhythm Society;Kapoor;Indian Pacing Electrophysiol. J.,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of the Prescription of Antibiotics During the Implementation of COVID-19 Personal Protection Measures in a Regional Health System;ClinicoEconomics and Outcomes Research;2021-11

2. Management of COVID-19 in patients with seizures: Mechanisms of action of potential COVID-19 drug treatments and consideration for potential drug-drug interactions with anti-seizure medications;Epilepsy Research;2021-08

3. Impact of mass and systematic antibiotic administration on antibiotic resistance in low- and middle-income countries? A systematic review;International Journal of Antimicrobial Agents;2021-07

4. Tackling the cytokine storm in COVID-19, challenges and hopes;Life Sciences;2020-09